Identification of tumor-associated antigens of lung cancer: SEREX combined with bioinformatics analysis.

[1]  L. Dai,et al.  Discovering novel lung cancer associated antigens and the utilization of their autoantibodies in detection of lung cancer. , 2019, Immunobiology.

[2]  L. Dai,et al.  A panel of autoantibodies against tumor-associated antigens in the early immunodiagnosis of lung cancer. , 2019, Immunobiology.

[3]  Bin Wang,et al.  Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis , 2019, Cancer Cell International.

[4]  C. Craik,et al.  The lysosomal aminopeptidase tripeptidyl peptidase 1 displays increased activity in malignant pancreatic cysts , 2019, Biological chemistry.

[5]  Rensheng Wang,et al.  Prognostic value of the mRNA expression of members of the HSP90 family in non-small cell lung cancer , 2019, Experimental and therapeutic medicine.

[6]  Yan Pan,et al.  TRIM37 promotes cell invasion and metastasis by regulating SIP1-mediated epithelial–mesenchymal transition in gastric cancer , 2018, OncoTargets and therapy.

[7]  C. Mu,et al.  TRIM37 targets AKT in the growth of lung cancer cells , 2018, OncoTargets and therapy.

[8]  Jian Zhao,et al.  Proliferation and invasion of colon cancer cells are suppressed by knockdown of TOP2A , 2018, Journal of cellular biochemistry.

[9]  Y. Yi,et al.  Identification of key pathways and genes in the progression of cervical cancer using bioinformatics analysis , 2018, Oncology letters.

[10]  X. An,et al.  The prognostic significance of topoisomerase II alpha protein in early stage luminal breast cancer , 2018, BMC Cancer.

[11]  Chin-Lee Wu,et al.  Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC) , 2017, Genomics data.

[12]  F. Feng,et al.  TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup , 2017, Clinical Cancer Research.

[13]  H. Pass,et al.  Identification of autoantibodies to ECH1 and HNRNPA2B1 as potential biomarkers in the early detection of lung cancer , 2017, Oncoimmunology.

[14]  S. Wen,et al.  Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan–Meier plotter , 2017, PloS one.

[15]  V. Filonenko,et al.  Panel of SEREX-defined antigens for breast cancer autoantibodies profile detection , 2017, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[16]  Cheng’en Hu,et al.  TRIM37 promotes epithelial-mesenchymal transition in colorectal cancer , 2017, Molecular medicine reports.

[17]  Simon Mitchell,et al.  Signaling via the NFκB system , 2016, Wiley interdisciplinary reviews. Systems biology and medicine.

[18]  Chengyi Sun,et al.  TRIM37 promoted the growth and migration of the pancreatic cancer cells , 2016, Tumor Biology.

[19]  M. Haase,et al.  HSP90AB1: Helping the good and the bad. , 2016, Gene.

[20]  Chengyi Sun,et al.  Over-expression of TRIM37 promotes cell migration and metastasis in hepatocellular carcinoma by activating Wnt/β-catenin signaling. , 2015, Biochemical and biophysical research communications.

[21]  Baolan Li,et al.  Plasma Levels of Heat Shock Protein 90 Alpha Associated with Lung Cancer Development and Treatment Responses , 2014, Clinical Cancer Research.

[22]  F. Kirchhoff,et al.  TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. , 2014, Developmental cell.

[23]  Guo-hong Xin,et al.  [Combination of phage display and SEREX for screening early lung cancer associated antigens]. , 2014, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences.

[24]  A. Weinhäusel,et al.  The current status of cancer biomarker research using tumour-associated antigens for minimal invasive and early cancer diagnostics. , 2012, Journal of proteomics.

[25]  D. Shin,et al.  Identification of the cancer/testis antigens AKAP3 and CTp11 by SEREX in hepatocellular carcinoma. , 2012, Oncology reports.

[26]  M. Katsogiannou,et al.  Small heat shock proteins HSP27 (HspB1), αB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death. , 2012, The international journal of biochemistry & cell biology.

[27]  J. Foekens,et al.  Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer , 2012, Breast Cancer Research and Treatment.

[28]  J. Solassol,et al.  Autoantibody signatures: progress and perspectives for early cancer detection , 2011, Journal of cellular and molecular medicine.

[29]  Sang-Yull Lee,et al.  Identification of BCP-20 (FBXO39) as a cancer/testis antigen from colon cancer patients by SEREX. , 2011, Biochemical and biophysical research communications.

[30]  J. Solassol,et al.  Clinical Relevance of Autoantibody Detection in Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[31]  Hwee Tong Tan,et al.  Serum autoantibodies as biomarkers for early cancer detection , 2009, The FEBS journal.

[32]  S. Ghosh,et al.  The NF-kappaB family of transcription factors and its regulation. , 2009, Cold Spring Harbor perspectives in biology.

[33]  L. Dai,et al.  Identification of tumor-associated antigens by using SEREX in hepatocellular carcinoma. , 2009, Cancer letters.

[34]  Young-Gyu Ko,et al.  Cathepsin D and eukaryotic translation elongation factor 1 as promising markers of cellular senescence. , 2009, Cancer research.

[35]  D. Ghosh,et al.  Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. , 2007, Cancer research.

[36]  J. O’Leary,et al.  Low-level TOP2A amplification in prostate cancer is associated with HER2 duplication, androgen resistance, and decreased survival. , 2007, Cancer research.

[37]  D. Sawyer,et al.  Heat shock proteins in cancer: chaperones of tumorigenesis. , 2006, Trends in biochemical sciences.

[38]  P. Fritz,et al.  c-erbB2 and topoisomerase IIα protein expression independently predict poor survival in primary human breast cancer: a retrospective study , 2005, Breast Cancer Research.

[39]  G. Brittinger,et al.  Topoisomerase IIα expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome , 2004, Leukemia.

[40]  L. Neckers,et al.  Heat shock protein 90 , 2003, Current opinion in oncology.

[41]  A. Ciechanover,et al.  Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  L. Dai,et al.  Screening of tumor-associated antigens based on Oncomine database and evaluation of diagnostic value of autoantibodies in lung cancer. , 2019, Clinical immunology.

[43]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[44]  L. Qin,et al.  Biological characteristics of heat shock protein 90 in human liver cancer cells. , 2019, American journal of translational research.

[45]  S. Abd Hamid,et al.  Human topoisomerase II alpha as a prognostic biomarker in cancer chemotherapy , 2015, Tumor Biology.